Back to results
US 2007/0191390 A1Published application
Substituted heterocyclic compounds
OwnerJeff Zablocki, Elfatih Elzein +1inventors
InventorsJeff Zablocki, Elfatih Elzein, Tim Marquart
Life of this patent
Estimating the term…
Abstract
Disclosed are novel heterocyclic compounds having the structure which are useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
Claims46
A compound of Formula I:
- wherein:
- R1, R2, R3, R4, R5, R6, R7, and R8 are hydrogen, lower alkyl, or —C(O)R;
- in which R is —OR9 or —NR12R13, where R12 and R13 are hydrogen or lower alkyl;
- or
- R1 and R2, R3 and R4, R5 and R6, R7 and R8, when taken together with the carbon to which they are attached, represent carbonyl;
- or
- R1 and R5, or R1 and R7, or R3 and R5, or R3 and R7, when taken together form a bridging group —(CR14R15)n—, in which n is 1, 2 or 3, and R14 and R15 are independently hydrogen or lower alkyl;
- with the proviso that
- (i) the maximum number of carbonyl groups is 2;
- and
- (ii) the maximum number of bridging groups is 1;
- R9 and R11 are independently optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted aryl, or optionally substituted heteroaryl;
- R10 is hydrogen or lower alkyl;
- T is oxygen, sulfur, or ═NR16, in which R16 is hydrogen, lower alkyl, cyano, lower alkoxy, or C(O)OR17, in which R17 is lower alkyl;
- X is —N< or —NH—CH<;
- Y is optionally substituted alkylene of 1-3 carbon atoms;
- and
- Z is —O—, —S—, —N(R18)— where R18 is hydrogen or lower alkyl, or a covalent bond.
15 more elements
Dependencies are inferred from the claim text.